NANBV diagnostics and vaccines

Details NANBV diagnostics and vaccines NANBV diagnostics and vaccines

1995-03-14

2002-02-12

Woodward, Michael P. (Department: 1643)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

C424S189100, C424S228100, C530S324000, C530S325000, C530S326000, C530S327000, C530S350000

Reexamination Certificate

active

06346375

ABSTRACT:

TECHNICAL FIELD
The invention relates to materials and methodologies for managing the spread of non-A, non-B hepatitis virus (NANBV) infection. More specifically, it relates to diagnostic DNA fragments, diagnostic proteins, diagnostic antibodies and protective antigens and antibodies for an etiologic agent of NANB hepatitis, i.e., hepatitis C virus.
REFERENCES CITED IN THE APPLICATION
Barr et al.,
Biotechniques
(1986) 4:428.
Bradley et al.,
Gastroenterology
(1985) 88:773.
Botstein,
Gene
(1979) 8:17.
M. A. Brinton, (1986) in “The Viruses: The Togaviridae and Flaviviridae” (Series eds.
Fraenkel-Conrat and Wagner, vol. eds. Schlesinger and Schlesinger, Plenum Press), p.327-374.
Broach (1981) in: “Molecular Biology of the Yeast—Saccharomyces, Vol. 1, p.445, Cold Spring Harbor Press.
Broach et al.,
Meth Enzymol
(1983) 101:307.
Catty (1988), “Antibodies, Volume 1: A Practical Approach” (IRL Press).
Chaney et al.,
Cell Mol Genet
(1986) 12:237.
Chakrabarti et al.,
Mol Cell Biol
(1985) 5:3403.
Chang et al.,
Nature
(1977) 198:1056.
Chen and Seeburg,
DNA
(1985) 4:165.
Chirgwin et al.,
Biochemistry
(1979) 18:5294.
Chomczynski and Sacchi,
Anal Biochem
(1987) 162:156.
Choo et al., Science (1989) 244:359.
Clewell et al.,
Proc Natl Acad Sci USA
(1969) 62:1159.
Clewell,
J Bacteriol
(1972) 110:667.
Cohen,
Proc Natl Acad Sci USA
(1972) 69:2110.
Cousens et al.,
Gene
(1987) 61:265.
De Boer et al.,
Proc Natl Acad Sci USA
(1983) 292:128.
Dreesman et al.,
J Infect Dis
(1985) 151:761.
S. M. Feinstone and J. H. Hoofnagle,
New Engl J Med
(1984) 311:185.
Felgner et al.,
Proc Natl Acad Sci USA
(1987) 84:7413.
Fields & Knipe (1986), “Fundamental Virology” (Raven Press, N.Y.).
Fiers et al.,
Nature
(1978) 273:113.
R. J. Gerety et al., in “Viral Hepatitis and Liver Disease” (B. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, eds)
Glennie et al.,
Nature
(1982) 295:712.
Gluzman,
Cell
(1981) 23:175.
Goeddel et al.,
Nuc Acids Res
(1980) 8:4057.
Graham and Van der Eb,
Virology
(1978) 52:546.
Grunstein and Hogness,
Proc Natl Acad Sci USA
(1975) 73:3961.
Grych et al.,
Nature
(1985) 316:74.
Gubler and Hoffman
Gene
(1983) 25:263.
Hahn,
Virology
(1988) 162:167.
Hammerling et al., (1981), “Monoclonal Antibodies and T-Cell Hybridomas”.
Han,
Biochemistry
(1987) 26:1617.
Helfman,
Proc Natl Acad Sci USA
(1983) 80:31.
Hess et al.,
J Adv Enzyme Reg
(1968) 7:149.
Hinnen et al.,
Proc Natl Acad Sci USA
(1978) 75:1929.
Hitzeman et al.,
J Biol Chem
(1980)255:2073.
Holland et al.,
Biochemistry
(1978) 17:4900.
Holland,
J Biol Chem
(1981) 256:1385.
Holland and Holland,
J Biol Chem
(1980) 255:2596.
Hoopes et al.,
Nuc Acids Res
(1981) 9:5493.
Houghton et al.,
Nuc Acids Res
(1981) 9:247
T. V. Hunyh et al., (1985) in “DNA Cloning Techniques; A Practical Approach” (D. Glover, Ed., IRL Press, Oxford, U.K.) pp. 49-78.
Immun Rev
(1982) 62:185.
Ito et al.,
Agric Biol Chem
(1984) 48:341.
Iwarson,
British Medical J
(1987) 295:946.
Kennett et al. (1980) “Monoclonal Antibodies”.
Kniskern et al.,
Gene
(1986) 46:135.
Kyte and Doolittle,
J Mol Bio
(1982) 157:105-132.
Laemmli,
Nature
(1970) 227:680.
Lee et al.,
Science
(1988) 239:1288.
Luckow and Summers,
Virol
(1989) 17:31.
Mackett et al.,
J Virol
(1984) 49:857.
T. Maniatis et al. (1982) “Molecular Cloning; A Laboratory Manual” (Cold Spring Harbor Press, Cold Spring Harbor, N.Y.).
Sambrook et al. (1989), “Molecular Cloning; A Laboratory Manual”, Second Edition (Cold Spring Harbor Press, Cold Spring Harbor, N.Y.).
Manning and Mocarski,
Virol
(1988) 167:477.
Mayer and Walker, eds. (1987), “Immunochemical Methods In Cell And Molecular Biology” (Academic Press, London).
Maxam et al.,
Meth Enzymol
(1980) 65:499.
MacNamara et al.,
Science
(1984) 226:1325.
Messing et al.,
Nuc Acids Res
(1981) 9:309.
Messing,
Meth Enzymol
(1983) 101:20-37.
Michelle et al., Int. Symposium on Viral Hepatitis.
Monath (1986) in “The Viruses: The Togaviradae And Flaviviridae” (Series eds. Fraenkel Conrat and Wagner, vol. eds. Schlesinger and Schlesinger, Plenum Press), pp. 375-440.
Moss (1987) in “Gene Transfer Vectors For Mammalian Cells” (Miller and Calos, eds., Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.), p. 10.
Nagahuma et al.,
Anal Biochem
(1984) 141:74.
Neurath et al.,
Science
(1984) 224:392.
Nisonoff et al.,
Clin Immunol Immunopathol
(1981) 21:397-406.
L. R. Overby,
Curr Hepatol
(1985) 5:49.
L. R. Overby,
Curr Hepatol
(1986) 6:65.
L. R. Overby,
Curr Hepatol
(1987) 7:35.
Pachl et al.,
J Virol
(1987) 61:315.
Peleg,
Nature
(1969) 221:193.
Pfefferkorn and Shapiro (1974), in “Comprehensive Virology”, Vol. 2 (Fraenkel-Conrat & Wagner, eds., Plenum, N.Y.) pp. 171-230.
A. M. Prince,
Ann Rev Microbiol
(1983) 37:217.
Rice et al.,
Science
(1985) 229:726.
Rice et al. (1986) in “The Viruses: The Togaviridae And Flaviviridae” (Series eds. Fraenkel-Conrat and Wagner, vol. eds. Schlesinger and Schlesinger, Plenum Press), p.279-328. Roehrig (1986) in “The Viruses: The Togaviridae And Flaviviridae” (Series eds. Fraenkel-Conrat and Wagner, vol. eds. Schlesinger and Schlesinger, Plenum Press)
Sadler et al., Gene (1980) 8:279.
Saiki et al., Nature (1986) 324:163.
Saiki et al.,
Science
(1988) 239:487.
Sanger et al.,
Proc Natl Acad Sci USA
(1977) 74:5463.
Setlow, ed. (1988), “Genetic Engineering” Vol. 10, pp. 195-219 (Plenum Publishing Co., N.Y.
Schlesinger et al.,
J Virol
(1986) 60:1153.
M. Schreier et al., (1980) “Hybridoma Techniques”
Scopes (1984), “Protein Purification, Principles and Practice”, 2nd Ed., (Springer-Verlag, N.Y.).
Shimatake et al.,
Nature
(1981) 292:128.
Singh et al.,
Nuc Acids Res
(1983) 11:4049.
Sippel,
Eur J Biochem
(1973) 37:31.
Smith et al.,
Mol Cell Biol
(1983) 3:2156-2165.
Steimer et al.,
J Virol
(1986) 58:9.
Stollar (1980), in “The Togaviruses” (R. W. Schlesinger, ed., Academic Press, N.Y.), pp. 584-622.
Stuve et al.,
J Virol
(1987) 61:326.
Sumiyoshi et al.,
Virol
(1987) 161:497.
Taylor et al.,
Biochim Biophys Acta
(1976) 442:324.
Towbin et al.,
Proc Natl Acad Sci USA
(1979) 76:4350.
Tsu and Herzenberg (1980), in “Selected Methods In Cellular Immunology” (W. H. Freeman and Co.) pp. 373-391.
Vytdehaag et al.,
J Immunol
(1985) 134:1225.
P. Valenzuela et al.,
Nature
(1982) 298:344.
P. Valenzuela et al., (1984), in “Hepatitis B” (I. Millman et al., ed, Plenum Press) pp. 225-236.
Warner,
DNA
(1984) 3:401.
Ward et al.,
Nature
(1989) 341:544.
Wu and Grossman,
Meth Enzymol
(1987), 154 “Recombinant DNA”, Part E.
Wu,
Meth Enzymol
(1987), 155, “Recombinant DNA”, part F.
Zoller,
Nuc Acids Res
(1982) 10:6487.
CITED PATENTS
U.S. Pat. No. 4,341,761
U.S. Pat. No. 4,399,121
U.S. Pat. No. 4,427,783
U.S. Pat. No. 4,444,887
U.S. Pat. No. 4,466,917
U.S. Pat. No. 4,472,500
U.S. Pat. No. 4,491,632
U.S. Pat. No. 4,493,890
U.S. Pat. No. 4,816,467
BACKGROUND ART
Non-A, Non-B hepatitis (NANBH) is a transmissible disease or family of diseases that are believed to be viral-induced, and that are distinguishable from other forms of viral-associated liver diseases, including that caused by the known hepatitis viruses, i.e., hepatitis A virus (HAV), hepatitis B virus (HBV), and delta hepatitis virus (HDV), as well as the hepatitis induced by cytomegalovirus (CMV) or Epstein-Barr virus (EBV). NANBH was first identified in transfused individuals. Transmission from man to chimpanzee and serial passage in chimpanzees provided evidence that NANBH is due to a transmissible infectious agent or agents. However, the transmissible agent responsible for NANBH is still unidentified and the number of agents which are causative of the disease are unknown.
Epidemiologic evidence is suggestive that there may be three types of NANBH: the water-borne epidemic type; the blood or needle associated type; and the sporadically occurring (community acquired) type. However, the number of agents which may be the causative of NANBH are unknown.
Clinical diagnosis and identification of NANBH has been accomplished primarily by exclusion of other viral markers. Among the methods used to detect putative NANBV an

Affiliated with

Also associated with

Rating

NANBV diagnostics and vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with NANBV diagnostics and vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NANBV diagnostics and vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2941522